Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

CytoSorbents files for FDA De Novo marketing approval of DrugSorb-ATR to reduce the severity of CABG-related bleeding due to the blood thinner ticagrelor
May 11, 2012 09:00 ET | Source: American Heart Association

Multiple Factors Influence Five-Year Survival After Angioplasty, Bypass Procedures

FRIDAY NEWS TIP Embargoed for 9 a.m. ET ATLANTA, May 11, 2012 (GLOBE NEWSWIRE) --The effectiveness of heart bypass grafts and angioplasty procedures on five-year survival varies significantly...